Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
300 participants
INTERVENTIONAL
2022-03-01
2024-08-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Outcomes for Care Partners of Persons With Traumatic Brain Injury
NCT04570930
Brief Interventions for Short-Term Suicide Risk Reduction in Military Populations
NCT02042131
Caring for the Carer
NCT07167641
The Effectiveness of a Post-ICU Recovery Program on Relatives
NCT03264365
Self-Management Behaviors of Caregivers of the Chronically Critically Ill
NCT03065829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Support as usual
Support as usual
This group receives current best practice which includes participation in ICU support groups and provision of community support resources
Problem Solving therapy
Problem solving therapy
This group will receive one on one therapy based on identifying stressors and solutions to those stressors
ICU diary
ICU diary
This group will be provided with a structured written diary that includes identification of stressors and development of solutions to those stressors
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Support as usual
This group receives current best practice which includes participation in ICU support groups and provision of community support resources
Problem solving therapy
This group will receive one on one therapy based on identifying stressors and solutions to those stressors
ICU diary
This group will be provided with a structured written diary that includes identification of stressors and development of solutions to those stressors
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caregiver and patient must report English as a primary language
* Patient and Caregiver must be able to provide informed consent
* Caregiver must be able to provide at least two forms of contact information
* Trauma Patient directly admitted to the ICU (Primary cause of admission is trauma, Injury must include trauma to the head/brain or polytrauma, Admitted directly to the hospital, Patient admission of at least 48 hours, Patient is currently admitted to the ICU, Patient is expected to survive more than 96 hours at 48 hours after admission, Patient has an abbreviated injury score greater than 3 (severe, critical, maximum), Fluent in English)
* Trauma patient must be able to communicate verbally
Exclusion
* Does not anticipate serving in a Caregiver role after the patient is discharged
* Caregiver is not a close friend or family member of the patient who has been admitted to the ICU
* Caregiver does not expect to serve in a supportive role to the patient
* Patient is not currently admitted to the ICU and or is not expected to remain in the ICU for 48 hours
* Patient is not expected to survive more than 96 hours
* Patient is not expected to require assistance prior to discharge
* Patient is not between 17 and 65 years of age
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deborah M Little
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deborah M Little, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-MS-19-0073
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.